Nadav Kidron

Filings by Nadav Kidron span 3 companies, the busiest being Oramed Pharmaceuticals Inc., Lifeward Ltd. and Nano Dimension Ltd. The record holds 54 filings, for trades running from 13 November 2014 to 24 September 2026.

The open-market side counts 16 purchases for €257k alongside 3 sales for €7.5M. Taken together, the sales exceed the purchases by €7.3M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 30 share grants and 1 option exercise.

Half of the purchases are above €1,620 and half below. Of 7 purchases, 2 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. After 16 purchases with a full 90-day history, the hit rate stands at 94% and the median 90-day move at +5.3%. These figures describe past trades and do not predict future prices.

Most recently, on 25 September 2026, the filings show a share grant in Oramed Pharmaceuticals Inc. The last insider purchase was made public on 16 March 2023, 1,319 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.